Exchange: OTC·Updated 12:57 PM EST

MEHCQ23andMe Holding Co

$3.50
$0.10
(2.78%)
Today
Mkt Cap$91.55M
Vol41,147.00
News
all
press releases
News Placeholder
23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA Privacy
A U.S. bankruptcy judge ruled that California's appeal to block the deal was unlikely to succeed, rejecting claims that the sale violated state genetic privacy laws.
Stocktwits
News Placeholder
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid
The deal encompasses 23andMe’s core genome testing service, research operations, and Lemonaid Health, with TTAM set to relaunch the company as a nonprofit organization committed to upholding existing data privacy policies.
Stocktwits
<
...
1
>

Advertisement|Remove ads.